Effect of Dexamethasone Palmitate-Low Density Lipoprotein Complex on Cholesterol Ester Accumulation in Aorta of Atherogenic Model Mice

概要

論文の詳細を見る
In order to confirm the efficacy of dexamethasone palmitate(DP)-low density lipoprotein(LDL)complex on experimental atherosclerosis in vivo, we examined whether DP-LDL complex could be effective for cholesterol ester accumulation in the aorta of atherogenic mice. Nonatherogenic and atherogenic mice were fed with normal and atherogenic diet for 14 weeks, respectively. Dexamethasone(DEX), lipid emulsion containing DP(DP-LE), or DP-LDL complex was intravenously injected once a week from 8 to 14 weeks. Cholesterol levels in serum and aorta in the atherogenic mice were significantly higher than those of nonatherogenic mice. Injection of DP-LDL complex significantly reduced cholesterol ester(CE)accumulation in the aorta of atherogenic mice. The reduction of CE accumulation in aorta treated with DP-LDL complexes was 10 and 100 times more potent than that with DP-LE and DEX, respectively. The radioactivity in the aorta of atherogenic mice treated with ^3H-DP-LDL complex was significantly higher than that with ^3H-DP-LE and ^3H-DEX at 24 h after injection. Even 7 d after injection, a significant amount of radioactivity was present only in the aorta of atherogenic mice treated with DP-LDL complex. This result suggests that DP-LDL complex is selectively delivered to the atherogenic lesions in the aorta of atherogenic mice, and then DP released from the complex inhibits CE accumulation in the aortic in-tima. Therefore, DP-LDL complex may be a good drug-carrier in drug delivery system for atherosclerosis.
公益社団法人日本薬学会の論文
2001-08-01

Effect of Dexamethasone Palmitate-Low Density Lipoprotein Complex on Cholesterol Ester Accumulation in Aorta of Atherogenic Model Mice

スポンサーリンク

概要

著者

関連論文

スポンサーリンク